Cargando…
Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis
BACKGROUND: While patients with cardiac transthyretin amyloidosis are easily diagnosed with bone scintigraphy, the detection of cardiac light chain (AL) amyloidosis is challenging. Cardiac magnetic resonance (CMR) analyses play an essential role in the differential diagnosis of cardiomyopathies; how...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191721/ https://www.ncbi.nlm.nih.gov/pubmed/35696411 http://dx.doi.org/10.1371/journal.pone.0269807 |
_version_ | 1784726078384766976 |
---|---|
author | Dohy, Zsofia Szabo, Liliana Pozsonyi, Zoltan Csecs, Ibolya Toth, Attila Suhai, Ferenc Imre Czimbalmos, Csilla Szucs, Andrea Kiss, Anna Reka Becker, David Merkely, Bela Vago, Hajnalka |
author_facet | Dohy, Zsofia Szabo, Liliana Pozsonyi, Zoltan Csecs, Ibolya Toth, Attila Suhai, Ferenc Imre Czimbalmos, Csilla Szucs, Andrea Kiss, Anna Reka Becker, David Merkely, Bela Vago, Hajnalka |
author_sort | Dohy, Zsofia |
collection | PubMed |
description | BACKGROUND: While patients with cardiac transthyretin amyloidosis are easily diagnosed with bone scintigraphy, the detection of cardiac light chain (AL) amyloidosis is challenging. Cardiac magnetic resonance (CMR) analyses play an essential role in the differential diagnosis of cardiomyopathies; however, limited data are available from cardiac AL-Amyloidosis. Hence, the purpose of the present study was to analyze the potential role of CMR in the detection of cardiac AL-amyloidosis. METHODS: We included 35 patients with proved cardiac AL-amyloidosis and two control groups constituted by 330 patients with hypertrophic cardiomyopathy (HCM) and 70 patients with arterial hypertension (HT), who underwent CMR examination. The phenotype and degree of left ventricular (LV) hypertrophy and the amount and pattern of late gadolinium enhancement (LGE) were evaluated. In addition, global and regional LV strain parameters were also analyzed using feature-tracking techniques. Sensitivity and specificity of several CMR parameters were analyzed in diagnosing cardiac AL-amyloidosis. RESULTS: The sensitivity and specificity of diffuse septal subendocardial LGE in diagnosing cardiac AL-amyloidosis was 88% and 100%, respectively. Likewise, the sensitivity and specificity of septal myocardial nulling prior to blood pool was 71% and 100%, respectively. In addition, a LV end-diastolic septal wall thickness ≥ 15 mm had an optimal diagnostic performance to differentiate cardiac AL-amyloidosis from HT (sensitivity 91%, specificity 89%). On the other hand, a reduced global LV longitudinal strain (< 15%) plus apical sparing (apex-to-base longitudinal strain > 2) had a very low sensitivity (6%) in detecting AL-Amyloidosis, but with very high specificity (100%). CONCLUSIONS: The findings from this study suggest that CMR could have an optimal diagnostic performance in the diagnosis of cardiac AL-amyloidosis. Hence, further larger studies are warranted to validate the findings from this study. |
format | Online Article Text |
id | pubmed-9191721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-91917212022-06-14 Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis Dohy, Zsofia Szabo, Liliana Pozsonyi, Zoltan Csecs, Ibolya Toth, Attila Suhai, Ferenc Imre Czimbalmos, Csilla Szucs, Andrea Kiss, Anna Reka Becker, David Merkely, Bela Vago, Hajnalka PLoS One Research Article BACKGROUND: While patients with cardiac transthyretin amyloidosis are easily diagnosed with bone scintigraphy, the detection of cardiac light chain (AL) amyloidosis is challenging. Cardiac magnetic resonance (CMR) analyses play an essential role in the differential diagnosis of cardiomyopathies; however, limited data are available from cardiac AL-Amyloidosis. Hence, the purpose of the present study was to analyze the potential role of CMR in the detection of cardiac AL-amyloidosis. METHODS: We included 35 patients with proved cardiac AL-amyloidosis and two control groups constituted by 330 patients with hypertrophic cardiomyopathy (HCM) and 70 patients with arterial hypertension (HT), who underwent CMR examination. The phenotype and degree of left ventricular (LV) hypertrophy and the amount and pattern of late gadolinium enhancement (LGE) were evaluated. In addition, global and regional LV strain parameters were also analyzed using feature-tracking techniques. Sensitivity and specificity of several CMR parameters were analyzed in diagnosing cardiac AL-amyloidosis. RESULTS: The sensitivity and specificity of diffuse septal subendocardial LGE in diagnosing cardiac AL-amyloidosis was 88% and 100%, respectively. Likewise, the sensitivity and specificity of septal myocardial nulling prior to blood pool was 71% and 100%, respectively. In addition, a LV end-diastolic septal wall thickness ≥ 15 mm had an optimal diagnostic performance to differentiate cardiac AL-amyloidosis from HT (sensitivity 91%, specificity 89%). On the other hand, a reduced global LV longitudinal strain (< 15%) plus apical sparing (apex-to-base longitudinal strain > 2) had a very low sensitivity (6%) in detecting AL-Amyloidosis, but with very high specificity (100%). CONCLUSIONS: The findings from this study suggest that CMR could have an optimal diagnostic performance in the diagnosis of cardiac AL-amyloidosis. Hence, further larger studies are warranted to validate the findings from this study. Public Library of Science 2022-06-13 /pmc/articles/PMC9191721/ /pubmed/35696411 http://dx.doi.org/10.1371/journal.pone.0269807 Text en © 2022 Dohy et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Dohy, Zsofia Szabo, Liliana Pozsonyi, Zoltan Csecs, Ibolya Toth, Attila Suhai, Ferenc Imre Czimbalmos, Csilla Szucs, Andrea Kiss, Anna Reka Becker, David Merkely, Bela Vago, Hajnalka Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
title | Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
title_full | Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
title_fullStr | Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
title_full_unstemmed | Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
title_short | Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
title_sort | potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191721/ https://www.ncbi.nlm.nih.gov/pubmed/35696411 http://dx.doi.org/10.1371/journal.pone.0269807 |
work_keys_str_mv | AT dohyzsofia potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT szaboliliana potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT pozsonyizoltan potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT csecsibolya potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT tothattila potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT suhaiferencimre potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT czimbalmoscsilla potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT szucsandrea potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT kissannareka potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT beckerdavid potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT merkelybela potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis AT vagohajnalka potentialclinicalrelevanceofcardiacmagneticresonancetodiagnosecardiaclightchainamyloidosis |